SEONGNAM,South Korea and BOSTON,Dec. 30,2024-- Bridge Biotherapeutics (KQ288330),a clinical-stage biotech company based inSouth Koreadeveloping novel drugs for fibrosis and cancer,today announced that

SHANGHAI,Dec. 30,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

NANTONG and SUZHOU,China,Dec. 31,2024-- Ractigen Therapeutics proudly announces that its Founder and CEO,Dr. Long-Cheng Li,has been honored with the 2024 Life Science Ice Breaking Award. This award,es

JIANGYIN,China,Dec. 31,2024-- SJ Semiconductor Corporation (hereinafter referred to as "SJSemi" or "the company") announced the efficient and successful closure of a new financing

STOCKHOLM,Dec. 31,2024--Autoliv,Inc. (NYSE: ALV) (SSE: ALIVsdb),the worldwide leader in automotive safety systems,today announced that as of December 31,2024,the total number of issued shares of commo

BEIJING,Dec. 31,2024-- New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK),a provider of private educational services in China